ApprovalTrail

Ingredient

Enoxaparin Sodium

Products in Health Canada’s databases that list Enoxaparin Sodium as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Drug products
46
45 authorized now
Natural health products
0
0 active licences
Notices of Compliance
41
Products in all
46

Drug products

Authorized products first.

NameDINStatus
AXBERI (30 MG)02539977Marketed
AXBERI (40 MG)02539985Marketed
AXBERI (60 MG)02540002Marketed
AXBERI (80 MG)02540010Marketed
AXBERI (100 MG)02540045Marketed
AXBERI HP (120 MG)02540029Marketed
AXBERI HP (150 MG)02540037Marketed
ELONOX (30 MG)02532247Marketed
ELONOX (40 MG)02532255Marketed
ELONOX (60 MG)02532263Marketed
ELONOX (80 MG)02532271Marketed
ELONOX (100 MG)02532298Marketed
ELONOX HP (120 MG)02532301Marketed
ELONOX HP (150 MG)02532328Marketed
INCLUNOX (30 MG)02507501Marketed
INCLUNOX (40 MG)02507528Marketed
INCLUNOX (60 MG)02507536Marketed
INCLUNOX (80 MG)02507544Marketed
INCLUNOX (100 MG)02507552Marketed
INCLUNOX HP (120 MG)02507560Marketed
INCLUNOX HP (150 MG)02507579Marketed
LOVENOX (30 MG)02012472Marketed
LOVENOX (40 MG)02236883Marketed
LOVENOX (60 MG)02378426Marketed
LOVENOX (80 MG)02378434Marketed
LOVENOX (100 MG)02378442Marketed
LOVENOX HP (120 MG)02242692Marketed
LOVENOX HP (150 MG)02378469Marketed
LOVENOX WITH PRESERVATIVE 300MG/3ML (100 MG)02236564Marketed
NOROMBY (30 MG)02506459Marketed
NOROMBY (40 MG)02506467Marketed
NOROMBY (60 MG)02506475Marketed
NOROMBY (80 MG)02506483Marketed
NOROMBY (100 MG)02506491Marketed
NOROMBY HP (120 MG)02506505Marketed
NOROMBY HP (150 MG)02506513Marketed
REDESCA (30 MG)02509075Marketed
REDESCA (40 MG)02509083Marketed
REDESCA (60 MG)02509091Marketed
REDESCA (80 MG)02509105Marketed
REDESCA (100 MG)02509113Marketed
REDESCA (300 MG)02509121Marketed
REDESCA HP (120 MG)02509148Marketed
REDESCA HP (150 MG)02509156Marketed
NOROMBY (20 MG)02506440Approved
LOVENOX HP (90 MG)02378450Cancelled Pre Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.